Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward V Loftus

Showing results (261-270 of 471) with videos related to

Pageof 48
Sort By:
Inflammatory Bowel Diseases|December 11, 2019
Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel DiseaseRaseen Tariq, Molly B Disbrow, John K Dibaise, et al.
Obesity Surgery|December 6, 2022
Endoscopic Bariatric Therapies for the Management of Obesity in Patients with Inflammatory Bowel DiseaseAmanda M Johnson, Andrew C Storm, Tala Mahmoud, et al.
Diseases of the Colon and Rectum|October 1, 2019
Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?Amy L Lightner, Nicholas P McKenna, Ahmad Alsughayer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2012
Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopySunil Samuel, David H Bruining, Edward V Loftus, et al.
Gastroenterology|February 26, 2008
Risk factors for opportunistic infections in patients with inflammatory bowel diseaseMurat Toruner, Edward V Loftus, W Scott Harmsen, et al.
Advances in Therapy|March 30, 2026
Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD TrialStefan Schreiber, Bruce E Sands, Silvio Danese, et al.
The American Journal of Gastroenterology|September 28, 2004
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's diseaseWilliam J Sandborn, Stephen Hanauer, Edward V Loftus, et al.
Therapeutic Advances in Gastroenterology|July 7, 2018
Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysisPaulo Gustavo Kotze, Christopher Ma, Nicholas Mckenna, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial ProgrammeTim Raine, Yoh Ishiguro, David T Rubin, et al.
Inflammatory Bowel Diseases|June 15, 2007
Internet use by patients in an inflammatory bowel disease specialty clinicRobert R Cima, Kari J Anderson, David W Larson, et al.
Pageof 48

Showing results (261-270 of 471) with videos related to

Sort By:
Pageof 48
Inflammatory Bowel Diseases|December 11, 2019
Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel DiseaseRaseen Tariq, Molly B Disbrow, John K Dibaise, et al.
Obesity Surgery|December 6, 2022
Endoscopic Bariatric Therapies for the Management of Obesity in Patients with Inflammatory Bowel DiseaseAmanda M Johnson, Andrew C Storm, Tala Mahmoud, et al.
Diseases of the Colon and Rectum|October 1, 2019
Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?Amy L Lightner, Nicholas P McKenna, Ahmad Alsughayer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2012
Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopySunil Samuel, David H Bruining, Edward V Loftus, et al.
Gastroenterology|February 26, 2008
Risk factors for opportunistic infections in patients with inflammatory bowel diseaseMurat Toruner, Edward V Loftus, W Scott Harmsen, et al.
Advances in Therapy|March 30, 2026
Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD TrialStefan Schreiber, Bruce E Sands, Silvio Danese, et al.
The American Journal of Gastroenterology|September 28, 2004
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's diseaseWilliam J Sandborn, Stephen Hanauer, Edward V Loftus, et al.
Therapeutic Advances in Gastroenterology|July 7, 2018
Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysisPaulo Gustavo Kotze, Christopher Ma, Nicholas Mckenna, et al.
Journal of Crohn'S & Colitis|November 9, 2023
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial ProgrammeTim Raine, Yoh Ishiguro, David T Rubin, et al.
Inflammatory Bowel Diseases|June 15, 2007
Internet use by patients in an inflammatory bowel disease specialty clinicRobert R Cima, Kari J Anderson, David W Larson, et al.
Pageof 48